Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance

  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Pamidronate Disodium for IV Infusion BP 60 mg
  Indications :
 

Hypercalcemia of Malignancy (Moderate to Severe)

Paget's Disease

Osteolytic Bone Metastases of Breast Cancer

Osteolytic Lesions of Multiple Myeloma

   
  Dosage :
  Moderate Hypercalcemia (serum calcium 12-13.5 mg/dL) : 60 to 90 mg given as a single-dose, intravenous infusion over 2 to 24 hours.

Severe Hypercalcemia (serum calcium >13.5 mg/dL) : 90 mg given as a single-dose, intravenous infusion over 2 to 24 hours.

Paget's Disease (Moderate to Severe ) : 30 mg daily, administered as a 4-hour infusion on 3 consecutive days for a total dose of 90 mg.

Osteolytic Lesions of Multiple Myeloma : 90 mg administered as a 4-hour infusion given on a monthly basis.

Osteolytic Bone Metastases of Breast Cancer : 90 mg administered over a 2-hour infusion given every 3-4 weeks.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : Not well studied, administer with caution.
   
  Packing : 5 Vials of 60 mg/Vial
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.